Bioxytran Using Paradigm Changing Vital Sign that Can Measure Real Time Tissue Oxygen Balance in Emergency Medicine
May 20, 2019 07:05 ET
|
Bioxytran Inc.
Future use of the MDX Viewer likely to start in operating rooms, clinical trials to measure tissue balance in stroke, and to test the viability of an organ before transplantation BOSTON,...
FLYHT to Present at the 20th Annual B. Riley FBR Investor Conference on May 23, 2019
May 20, 2019 07:04 ET
|
FLYHT Aerospace Solutions Ltd.
CALGARY, Alberta, May 20, 2019 (GLOBE NEWSWIRE) -- FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) has been invited to present at the 20th Annual B. Riley FBR...
Elemica Drives Innovation with Recent Supply Chain Quality Solution Acquisition
May 20, 2019 07:03 ET
|
Elemica
ATLANTA, May 20, 2019 (GLOBE NEWSWIRE) -- Elemica, the leading Digital Supply Network for process manufacturing industries, announced today two significant client enhancements within their Supply...
Conferize A/S indkalder til ekstraordinær generalforsamling
May 20, 2019 07:01 ET
|
Conferize A/S
Selskabsmeddelelse Nr. 15/2019København, 20. maj 2019 Indkaldelse til ekstraordinær generalforsamlingConferize A/S, cvr. 34472742 Der indkaldes hermed til ekstraordinær...
Siemplify Closes $30M in Series C Financing
May 20, 2019 07:00 ET
|
Siemplify
NEW YORK and TEL AVIV, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Siemplify, the leading independent provider of security orchestration, automation and response (SOAR), today announced that it has...
Exklusive Forschungskooperation zwischen CureVac und dem Schepens Eye Research Institute der Harvard Medical School und deren Massachusetts Eye and Ear Infirmary zur Erforschung mRNA-basierter Arzneimittelkandidaten für die Behandlung von Augenerkrankungen
May 20, 2019 07:00 ET
|
CureVac AG
TÜBINGEN, Deutschland / BOSTON, MA, May 20, 2019 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehmen CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gab heute den...
Akoustis Announces Production Shipments of Its 3.8 GHz XBAW Filter and Receives Fourth Production Order from Defense Customer
May 20, 2019 07:00 ET
|
Akoustis, Inc.
– First Three Open 3.8 GHz Orders Scheduled to Ship in the Current Quarter – – Company Expects to Receive Order for New Defense Program Requiring Multiple New Filters with Frequency Bands Synergistic...
NUGL Records Consecutive Quarterly Growth with Accelerating Revenues
May 20, 2019 07:00 ET
|
NUGL Inc.
Revenue Growth Occurs as Company Greatly Reduces Corporate Debt LOS ANGELES, CA, May 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NUGL Inc. (OTC: NUGL) (the “Company”), a technology and...
Axovant to Present at 2019 RBC Capital Markets Global Healthcare Conference
May 20, 2019 07:00 ET
|
Axovant Sciences Ltd.
BASEL, Switzerland, May 20, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Pavan Cheruvu,...
Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress
May 20, 2019 07:00 ET
|
Stemline Therapeutics, Inc.
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology...